Popular pre-post methodologies may overstate savings in disease management outcomes measurement.
How can you, your consultant, or your vendor know whether you saved money in disease management, if you don’t know whether your key utilization indicators changed, and how that change compares to others? Without that key information, you have no idea if the outcomes being shown to you are plausible.
Further, you have no idea how much those adverse event rates must decline in order to earn a return on your investment. How can you manage something if you don't have goals and if you can't measure success?
Disease Management Outcomes Measurement, a webinar on CD, will answer all those questions, provide benchmarkable data from many payors and show you the surprising results of valid measurement from two organizations widely recognized for their disease management:
- Harvard-Pilgrim -- #1 in the country overall according to JD Power, and also #1 (tied) in disease management outcomes according to the Disease Management Purchasing Consortium, and has won a HIRC award for excellence in disease management four times
- The City of Savannah is a leader, also having won a HIRC award for its own programs as one of the top-ten employer-driven programs in the nation
The good news is, with these materials and CD, you can measure your own outcomes (a) validly (b) without needing any consultants -- by tallying your event rates, following what is now the single most widely used methodology in the country, event-rate-based “plausibility analysis.” You can count your events, determine your trend, compare them to benchmarks, and develop an ROI…on your own.
In addition to the basic package, you may optionally order the full complement of how-to-measure-ROI materials (including the actual tool into which you can enter your own data) and obtain a free one-hour Q&A session with the principal speaker.
Your payoff? Actual valid measurement of your own outcomes, using “ingredients you already have in your kitchen.” If you sign up for the full package, including the consultation, this outcome is guaranteed, or the consultations continue until you’ve accomplished it.
Faculty
Al Lewis, widely credited with having invented disease management, is co-author of the only book in print on the topic: The Next Generation of Disease Management. He was founder and first president of the Disease Management Association of America, and is founder and president of the Disease Management Purchasing Consortium. More than 200 people have received his certification in Critical Outcomes Report Analysis. All are listed on www.dismgmt.com and serve as references for this program, in addition to the testimonials above. Mr. Lewis is consistently ranked #1 in the quadrennial Managed Healthcare Executive report on the leaders in the disease management industry. His writings on health care have been featured in many newspapers as well as Newsweek.
Dr. Soeren Mattke is a Senior Scientist at RAND Corporation and the Managing Director of RAND Health Advisory, the consulting practice of RAND Health. He is an expert in developing and evaluating interventions to improve the quality and efficiency of care with a focus on care for chronic conditions. He was the lead author of the landmark study "Evidence for the Effect of Disease Management: Is $1 Billion a year a good investment?" Prior to coming to RAND, he worked at the Organization for Economic Co-operation and Development (OECD), an intergovernmental research organization in Paris, where he directed a project to collect internationally comparable data on quality of care, at Bain & Company, a management consultancy, at Abt Associates, a public policy consulting firm, and at Harvard University. Soeren holds an MD from the University of Munich, Germany, where he trained in internal medicine and cardiology and a Doctor of Science in Health Policy from Harvard.
Beth Robinson, Human Resources Director for the City of Savannah, oversees one of the ten disease management programs in the country that have won a “Best Employer in Disease Management” award from the Health Industries Research Council. She presents an example of the methodology, as applied to the City of Savannah.
Here’s what participants have said about the program:
“I would heartily recommend this program to anyone interested in validly measuring care management outcomes. It's a real eye-opener, and very clearly presented.” --Melissa Tobler, Vice President, Health Strategies, Hays Companies
""Outcome Measurement for Dummies and Smarties" provides the state of the art approach to measuring return on investment for disease management and are the clear leaders in the field. Al's ‘plausibility approach’ ensures that your ROI model will properly quantify the changes you achieve with your interventions, and that from there you will have a credible, understandable and accurate portrayal of results which will even stand up to CFO scrutiny. If everyone measured ROI in this manner, the credibility of the outcomes would propel disease management to the next level." Richard Citrin, Principal, Working Well (formerly Vice President, UPMC Health Plan)
"Really enjoyed the presentation." Geoffrey Cole MD, Medical
Director and Director of Provider Relations, Health Plan Select
"Did an amazing job of both educating and entertaining our team – we learned a lot from him and had fun doing it. I highly recommend this course to anyone that would benefit from insight into DM outcomes measurement. Thanks!." Emily Adams, Director, Pricing and Business Development Analytics, Take Care Health Systems
"After you watch this show, you will immediately want to reevaluate your metrics. It's a real eye-opener, the magnum opus of the #1 guy in the field and his equally insightful co-presenters." David Bendich MD